Ampiroxicam
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration |
Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.235.757 |
| Chemical and physical data | |
| Formula | C20H21N3O7S |
| Molar mass | 447.46 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
|
| |
Ampiroxicam (INN) is a non-steroidal anti-inflammatory drug (NSAID). It is a prodrug of piroxicam.
|
pyrazolones / pyrazolidines |
|
|---|---|
| salicylates | |
|
acetic acid derivatives and related substances |
|
| oxicams | |
|
propionic acid derivatives (profens) |
|
|
n-arylanthranilic acids (fenamates) |
|
|
COX-2 inhibitors (coxibs) |
|
| other | |
| NSAID combinations |
|
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |